[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Embecta Corp (EMBC)

Embecta Corp (EMBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 198,155
  • Shares Outstanding, K 59,328
  • Annual Sales, $ 1,080 M
  • Annual Income, $ 95,400 K
  • EBIT $ 269 M
  • EBITDA $ 329 M
  • 60-Month Beta 0.84
  • Price/Sales 0.19
  • Price/Cash Flow 0.84
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 115.62% (-0.93%)
  • Historical Volatility 252.11%
  • IV Percentile 89%
  • IV Rank 46.02%
  • IV High 202.64% on 05/15/26
  • IV Low 41.45% on 07/11/25
  • Expected Move (DTE 8) 0.77 (23.11%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 38
  • Volume Avg (30-Day) 164
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 6,222
  • Open Int (30-Day) 6,503
  • Expected Range 2.55 to 4.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.26
  • Number of Estimates 1
  • High Estimate $0.26
  • Low Estimate $0.26
  • Prior Year $1.12
  • Growth Rate Est. (year over year) -76.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.77 +19.49%
on 05/20/26
3.77 -12.20%
on 05/11/26
-0.33 (-9.07%)
since 05/08/26
3-Month
2.77 +19.49%
on 05/20/26
9.90 -66.57%
on 04/20/26
-5.92 (-64.14%)
since 03/09/26
52-Week
2.77 +19.49%
on 05/20/26
15.55 -78.71%
on 09/17/25
-6.60 (-66.60%)
since 06/09/25

Most Recent Stories

More News
Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

NEW YORK , June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading...

VIAV : 46.43 (-4.76%)
ROKU : 120.91 (-2.15%)
VITL : 10.48 (+4.17%)
LAZ : 47.30 (+3.41%)
CDE : 16.09 (-3.83%)
OXM : 43.16 (-3.05%)
IVT : 34.68 (+1.17%)
EBC : 20.59 (+0.64%)
PRAA : 15.54 (+2.24%)
CNXC : 27.29 (-0.33%)
EMBC : 3.31 (-0.90%)
CTKB : 4.13 (+2.23%)
embecta to Participate in Investor Events

PARSIPPANY, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical...

EMBC : 3.31 (-0.90%)
Levi & Korsinsky Investigating Whether Embecta Corp. (EMBC) Misled Investors - Securities Law Violations Possible

New York, New York--(Newsfile Corp. - May 21, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Embecta Corp. ("Embecta Corp.") (NASDAQ: EMBC) concerning potential...

EMBC : 3.31 (-0.90%)
EMBC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Embecta Corp. (“Embecta” or the “Company”) (NASDAQ:EMBC) investors concerning the Company’s...

EMBC : 3.31 (-0.90%)
Embecta Corp. (EMBC) Securities Fraud Investigation - Levi & Korsinsky

Embecta's Q2 FY2026 revenue and EPS fell short of both company guidance and Wall Street consensus -- shares dropped more than 25% in a single session.

EMBC : 3.31 (-0.90%)
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and inventory-related...

EMBC : 3.31 (-0.90%)
embecta Completes Acquisition of Owen Mumford Holdings Limited

PARSIPPANY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced...

EMBC : 3.31 (-0.90%)
EMBC Investor Alert: Levi & Korsinsky Investigates Embecta Corp. (EMBC) for Potential Securities Fraud

Embecta guided investors toward a $1.071-$1.093 billion revenue outlook for FY2026 while internal indicators reportedly already signaled the need for a cut -- shares later fell more than 25%.

EMBC : 3.31 (-0.90%)
embecta to Participate at the 2026 BofA Securities Global Health Care Conference

PARSIPPANY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the 2026 BofA Securities Global Health Care Conference in Las...

EMBC : 3.31 (-0.90%)
EMBC ACTIVE INVESTIGATION: Lost Money on Embecta Corp.? Contact Levi & Korsinsky Now

New York, New York--(Newsfile Corp. - May 7, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Embecta Corp. ("Embecta Corp.") (NASDAQ: EMBC) concerning potential...

EMBC : 3.31 (-0.90%)

Business Summary

Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J.

See More

Key Turning Points

3rd Resistance Point 3.58
2nd Resistance Point 3.50
1st Resistance Point 3.41
Last Price 3.31
1st Support Level 3.23
2nd Support Level 3.15
3rd Support Level 3.06

See More

52-Week High 15.55
Fibonacci 61.8% 10.67
Fibonacci 50% 9.16
Fibonacci 38.2% 7.65
Last Price 3.31
52-Week Low 2.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.